Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia

Oncogene

Volumn 32, Issue 25, 2013, Pages 3039-3048

  Chen, D W C ^a   Saha, V ^a   Liu, J Z ^a   Schwartz, J M ^a   Krstic Demonacos, M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

dynamic model; gene expression; glucocorticoid receptor; systems biology

Indexed keywords

BIM PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CLUSTER ANALYSIS; ETS RELATED GENE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; DEXAMETHASONE; GENES, FOS; GLUCOCORTICOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE PROTEINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84879422529     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.321     Document Type: Article

References (73)

1. Wen LP, Madani K, Fahrni JA, Duncan SR, Rosen GD. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-g and Fas. Am J Physiol Lung Cell Mol Physiol 1997; 273: L921-L929.
2. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Ann Rev Genet 1985; 19: 209-252.
3. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003; 278: 23861-23867.
4. Chen DWC, Lynch JT, Demonacos C, Krstic-Demonacos M, Schwartz J-M. Quantitative analysis and modeling of glucocorticoid-controlled gene expression. Pharmacogenomics 2010; 11: 1545-1560.
5. Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S et al. The Bcl2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2007; 22: 370-377.
6. Miller A, Komak S, Webb SM, Leiter E, Thompson EB. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids. Cancer Cell Int 2007; 7: 18.
7. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15: 1481-1486.
8. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L et al. BH3-only proteins puma and Bim are rate-limiting for gamma-radiation-and glucocorti-coid-induced apoptosis of lymphoid cells in vivo. Blood 2005; 106: 4131-4138.
9. So AYL, Chaivorapol C, Bolton EC, Li H, Yamamoto KR. Determinants of cell-and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 2007; 3: e94.
10. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452-460.
11. Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 2001; 276: 42714-42721.
12. Geng CD, Vedeckis WV. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1a promoter. J Biol Chem 2005; 280: 43264-43271.
13. White RJ, Sharrocks AD. Coordinated control of the gene expression machinery. Trends Genet 26: 214-220.
14. Davies L, Karthikeyan N, Lynch JT, Sial E-A, Gkourtsa A, Demonacos C et al. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol 2008; 22: 1331-1344.
15. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate tran-scriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 1997; 17: 3947-3954.
16. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266-1272.
17. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kb or activator protein-1: molecular mechanisms for gene repression. Endocrine Rev 2003; 24: 488-522.
18. Segal E, Friedman N, Kaminski N, Regev A, Koller D. From signatures to models: understanding cancer using microarrays. Nat Genet. 2005; 37(Suppl): S38-S45.
19. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lympho-blastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
20. Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004; 36: 1090-1098.
21. Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmaco-genomics in rat liver using gene microarrays. J Pharmacol Exp Ther 2003; 307: 93-109.
22. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, NCS Program, Liechty KW et al. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. PNAS 2010; 107: 14799-14804.
23. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M et al. Gene profiling reveals unknown enhancing and suppressive actions of gluco-corticoids on immune cells. FASEB J 2002; 16: 61-71.
24. Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmüller C et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006; 107: 2061-2069.
25. Tsuzuki S, Taguchi O, Seto M. Promotion and maintenance of leukemia by erg. Blood 2011; 10: 1182.
26. Thoms JAI, Birger Y, Foster S, Knezevic K, Kirschenbaum Y, Chandrakanthan V et al. Erg promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer. Blood 2011; 117: 7079-7089.
27. Martens J. Acute myeloid leukemia: A central role for the Ets factor Erg. Int J Biochem Cell Biol 2011; 43: 1413-1416.
28. Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L et al. A small molecule blocking oncogenic protein Ews-Fli1 interaction with rna helicase a inhibits growth of ewing's sarcoma. Nat Med 2009; 15: 750-756.
29. Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Üren A. YK-4-279 inhibits Erg and Etv1 mediated prostate cancer cell invasion. PLoS One 2011; 6: e19343.
30. Ernst J, Bar-Joseph Z. Stem: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 2006; 7: 191.
31. Zhou F, Thompson EB. Role of c-Jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Mol Endocrinol 1996; 10: 306-316.
32. Biswas SC, Shi Y, Sproul A, Greene LA. Pro-apoptotic Bim induction in response to nerve growth factor deprivation requires simultaneous activation of three different death signaling pathways. J Biol Chem 2007; 282: 29368-29374.
33. Zhao F, Xuan Z, Liu L, Zhang MQ. TRED: A transcriptional regulatory element database and a platform for in silico gene regulation studies. Nucleic Acids Res 2005; 33: D103-D107.
34. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of affymetrix genechip probe level data. Nucleic Acids Res 2003; 31: e15.
35. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004; 36: 1199-1207.
36. Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TOB et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK medical research council ALL97 randomized trial. Br J Haematol 2005; 129: 734-745.
37. Verger A, Buisine E, Carrère S, Wintjens R, Flourens A, Coll J et al. Identification of amino acid residues in the Ets transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation. J Biol Chem 2001; 276: 17181-17189.
38. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006; 38: 1289-1297.
39. Cai J, Kandagatla P, Singareddy R, Kropinski A, Sheng S, Cher ML et al. Androgens induce functional Cxcr4 through Erg factor expression in Tmprss2-Erg fusion-positive prostate cancer cells. Transl Oncol 2010; 3: 195-203.
40. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 2003; 22: 6035-6044.
41. Caelles C, González-Sancho JM, Muñoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 1997; 11: 3351-3364.
42. Miner JN, Yamamoto KR. The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev 1992; 6: 2491-2501.
43. Pearce D, Matsui W, Miner JN, Yamamoto KR. Glucocorticoid receptor transcrip-tional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 1998; 273: 30081-30085.
44. Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell 2001; 43: 145-155.
45. Hollenhorst PC, Ferris MW, Hull MA, Chae H, Kim S, Graves BJ. Oncogenic Ets proteins mimic activated Ras/MAPK signaling in prostate cells. Genes Dev 2011; 25: 2147-2157.
46. Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible protein Gilz. J Biol Chem 2001; 276: 29603-29610.
47. Shaulian E, Karin M. AP-1as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131-E136.
48. Leung KT, Li KKH, Sun SSM, Chan PKS, Ooi VEC, Chiu LCM. Activation of the JNK pathway promotes phosphorylation and degradation of BIMEL-a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. Carcino-genesis 2008; 29: 544-551.
49. Barrett TJ, Vig E, Vedeckis WV. Coordinate regulation of glucocorticoid receptor and c-Jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down-and up-regulation. Biochemistry 1996; 35: 9746-9753.
50. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor-kb in human neutrophils. J Biol Chem 2004; 279: 2657-2665.
51. Qi X, Pramanik R, Wang J, Schultz RM, Maitra RK, Han J et al. The p38 and JNK pathways cooperate to trans-activate vitamin d receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D3-induced growth inhibition. J Biol Chem 2002; 277: 25884-25892.
52. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993; 7: 2135-2148.
53. Li L, Feng Z, Porter AG. JNK-dependent phosphorylation of c-Jun on serine 63 mediates nitric oxide-induced apoptosis of neuroblastoma cells. J Biol Chem 2004; 279: 4058-4065.
54. Seth A, Watson DK. Ets transcription factors and their emerging roles in human cancer. Eur J Cancer 2005; 41: 2462-2478.
55. Baldus CD, Burmeister T, Martus P, Schwartz S, Gökbuget N, Bloomfield CD et al. High expression of the Ets transcription factor Erg predicts adverse outcome in acute T-lymphoblastic leukemia in adults. JCO 2006; 24: 4714-4720.
56. Baldus CD, Martus P, Burmeister T, Schwartz S, Gökbuget N, Bloomfield CD et al. Low Erg and Baalc expression identifies a new subgroup of adult acute T-lympho-blastic leukemia with a highly favorable outcome. JCO 2007; 25: 3739-3745.
57. Basuyaux JP, Ferreira E, Stéhelin D, Buttice G. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and-independent manner. J Biol Chem 1997; 272: 26188-26195.
58. Birdsey GM, Dryden NH, Amsellem V, Gebhardt F, Sahnan K, Haskard DO et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 2008; 111: 3498-3506.
59. Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B et al. Tmprss2-Erg fusion, a common genomic alteration in prostate cancer activates c-Myc and abrogates prostate epithelial differentiation. Oncogene 2008; 27: 5348-5353.
60. Medh RD, Wang A, Zhou F, Thompson EB. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Oncogene 2001; 20: 4269-4639.
61. Löffler M, Ausserlechner MJ, Tonko M, Hartmann BL, Bernhard D, Geley S et al. c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts. Oncogene 1999; 18: 4646-4631.
62. Yi HK, Fujimura Y, Ouchida M, Prasad DDK, Rao VN, Reddy ESP. Inhibition of apoptosis by normal and aberrant Fli-1 and Erg proteins involved in human solid tumors and leukemias. Oncogene 1997; 14: 1259-1268.
63. Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O et al. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-XL-dependent mechanism. Mol Cell Biol 1999; 19: 2624-2634.
64. Medh RD, Saeed MF, Johnson BH, Thompson EB. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: Correlation with c-Myc suppression. Cancer Res 1998; 58: 3684-3693.
65. Li C, Wong W. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-36.
66. Bolstad B, Irizarry R, Astrand M, Speed T. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioin-formatics 2003; 19: 185-193.
67. Smyth G. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3; article 3.
68. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
69. Ernst J, Nau GJ, Bar-Joseph Z. Clustering short time series gene expression data. Bioinformatics 2005; 21: i159-i168.
70. Xenaki G, Ontikatze T, Rajendran R, Stratford IJ, Dive C, Krstic-Demonacos M et al. Pcaf is an Hif-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 2008; 27: 5785-5796.
71. Lynch J, Rajendran R, Xenaki G, Berrou I, Demonacos C, Krstic-Demonacos M. The role of glucocorticoid receptor phosphorylation in Mcl-1 and Noxa gene expression. Mol Cancer 2010; 9: 38.
72. Schmidt D, Wilson MD, Spyrou C, Brown GD, Hadfield J, Odom DT. Chip-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 2009; 48: 240-248.
73. Al-Shahrour F, D́iaz-Uriarte R, Dopazo J. Fatigo: A web tool for finding significant associations of gene ontology terms with groups of genes. Bioinformatics 2004; 20: 578-580.